Literature DB >> 25940973

Response to letter regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms".

Shirya Rashid1, Hagai Tavori2, Patrick E Brown3, MacRae F Linton4, Jane He4, Ilaria Giunzioni2, Sergio Fazio2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25940973      PMCID： PMC4547604          DOI： 10.1161/CIRCULATIONAHA.114.013729

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.

Authors:  Shirya Rashid; David E Curtis; Rita Garuti; Norma N Anderson; Yuriy Bashmakov; Y K Ho; Robert E Hammer; Young-Ah Moon; Jay D Horton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-01       Impact factor: 11.205

2.  PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells.

Authors:  Emile Levy; Ali Ben Djoudi Ouadda; Schohraya Spahis; Alain Théophile Sane; Carole Garofalo; Émilie Grenier; Lea Emonnot; Sabrina Yara; Patrick Couture; Jean-François Beaulieu; Daniel Ménard; Nabil G Seidah; Mounib Elchebly
Journal:  Atherosclerosis       Date:  2013-02-04       Impact factor: 5.162

3.  Proprotein convertase subtilisin kexin type 9 null mice are protected from postprandial triglyceridemia.

Authors:  Cédric Le May; Sanae Kourimate; Cédric Langhi; Maud Chétiveaux; Anne Jarry; Christine Comera; Xavier Collet; Folkert Kuipers; Michel Krempf; Bertrand Cariou; Philippe Costet
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-05       Impact factor: 8.311

4.  Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment.

Authors:  Gilles Lambert; Nicolas Ancellin; Francesca Charlton; Daniel Comas; Julia Pilot; Anthony Keech; Sanjay Patel; David R Sullivan; Jeffrey S Cohn; Kerry-Anne Rye; Philip J Barter
Journal:  Clin Chem       Date:  2008-04-24       Impact factor: 8.327

5.  Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.

Authors:  Shirya Rashid; Hagai Tavori; Patrick E Brown; MacRae F Linton; Jane He; Ilaria Giunzioni; Sergio Fazio
Journal:  Circulation       Date:  2014-05-23       Impact factor: 29.690
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.